SUBSCRIBE
SUBSCRIBE
News   Drug Development

Covance Inc. Increases Its Phase I Clinical Capacity With Acquisition Of Gfi Research Center

October 26, 2005 | 
1 min read
Covance Inc. (NYSE: CVD) added to its Phase I capacity and further enhanced its reputation for clinical excellence with the purchase today of GFI Clinical Services from West Pharmaceutical Services, Inc. (NYSE: WST).
Clinical research Phase 1 Mergers & acquisitions
MORE ON THIS TOPIC
Row of Falling Domino Stones Stopped by Red Domino Stone Over Black Background, Risk Management, Intervene or Prevention Concept, 3d Rendering
Cancer
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
August 28, 2026
 · 
2 min read
 · 
Heather McKenzie
Iridescent colors abstract shapes on tar water surface of natural asphalt pit.
cardiovascular disease
‘Worse than expected’ Wainua data muddies water for TTR silencers
August 28, 2026
 · 
2 min read
 · 
Gabrielle Masson
An architect designs a building on a laptop. Art collage.
Insights
Multispecifics are transforming the CDMO development architecture
August 28, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.
Drug Development
Generate Bio drops as data accidentally leaked ahead of European conference
August 27, 2026
 · 
2 min read
 · 
Gabrielle Masson